Literature DB >> 25183420

Bone regeneration at dental implant sites with suspended stem cells.

R C Zheng1, Y K Park2, J J Cho3, S K Kim4, S J Heo5, J Y Koak5, J H Lee6.   

Abstract

During the maintenance of bone marrow-derived mesenchymal stem cells (BMMSCs), suspended cells are discarded normally. We noted the osteogenic potential of these cells to be like that of anchorage-dependent BMMSCs. Therefore, we characterized suspended BMMSCs from rabbit bone marrow by bioengineering and applied the suspended BMMSCs to double-canaled dental implants inserted into rabbits. After primary isolation of BMMSCs, we collected the suspended cells during primary culture on the third day. The cells were transferred and maintained on an extracellular-matrix-coated culture plate. The cells were characterized and compared with BMMSCs by colony-forming-unit fibroblast (CFU-f) and cell proliferation assay, fluorescence-activated cell sorter (FACS), in vitro multipotency, and reverse transcription polymerase chain reaction (RT-PCR). We also analyzed the osteogenic potential of cells mixed with hydroxyapatite/tricalcium phosphate (HA/TCP) and transplanted into immunocompromised mice. We compared the viability and proliferation of the suspended BMMSCs and BMMSCs on the titanium implant surface and observed cell morphology. Then, the cells mixed with HA/TCP were applied to the double-canaled implants during installation into rabbit tibia. Four weeks later, we analyzed bone formation inside the canal by histomorphometry. The suspended cells showed higher CFU-f on the extracellular matrix (ECM)-coated culture plate and similar results of proliferation capacity compared with BMMSCs. The cells also showed osteogenic, adipogenic, and chondrogenic ability. The suspended cells showed levels of attachment survival and proliferation on the surfaces of titanium implant discs to be higher than or similar to those of BMMSCs. The suspended cells as well as BMMSCs showed stronger bone formation ability in both upper and lower canals of the implants compared with controls on double-canaled implants inserted into rabbit tibia. In this study, we showed that suspended cells after primary BMMSC isolation have bone regeneration capacity like that of BMMSCs, not only in vitro but also in vivo. ECM was valuable for propagation of MSCs for cell-based bone regeneration. Therefore, the suspended cells could also be useful tools for bone regeneration after implant surgery. © International & American Associations for Dental Research.

Entities:  

Keywords:  bone marrow stromal cells; extracellular; implantation; matrix; mesenchymal stem cell transplantation; suspensions

Mesh:

Substances:

Year:  2014        PMID: 25183420      PMCID: PMC4293714          DOI: 10.1177/0022034514548706

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  25 in total

1.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

2.  A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse.

Authors:  J E Dennis; A Merriam; A Awadallah; J U Yoo; B Johnstone; A I Caplan
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

Review 3.  Localized ridge augmentation with autografts and barrier membranes.

Authors:  D Buser; K Dula; D Hess; H P Hirt; U C Belser
Journal:  Periodontol 2000       Date:  1999-02       Impact factor: 7.589

4.  Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.

Authors:  Z L Zhang; J Tong; R N Lu; A M Scutt; D Goltzman; D S Miao
Journal:  Bone Marrow Transplant       Date:  2008-08-18       Impact factor: 5.483

5.  Autologous bone marrow transplantation/mobilization: a potential regenerative medicine for systemic degenerative disorders and healthy living.

Authors:  Meenal Banerjee; Ramesh R Bhonde
Journal:  Med Hypotheses       Date:  2007-01-02       Impact factor: 1.538

6.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering.

Authors:  G Ciapetti; L Ambrosio; G Marletta; N Baldini; A Giunti
Journal:  Biomaterials       Date:  2006-09-11       Impact factor: 12.479

8.  Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites.

Authors:  T Noshi; T Yoshikawa; Y Dohi; M Ikeuchi; K Horiuchi; K Ichijima; M Sugimura; K Yonemasu; H Ohgushi
Journal:  Artif Organs       Date:  2001-03       Impact factor: 3.094

9.  The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.

Authors:  Xiao-Dong Chen; Larry W Fisher; Pamela Gehron Robey; Marian F Young
Journal:  FASEB J       Date:  2004-06       Impact factor: 5.191

10.  Long-term in vitro expansion alters the biology of adult mesenchymal stem cells.

Authors:  Reza Izadpanah; Deepak Kaushal; Christopher Kriedt; Fern Tsien; Bindiya Patel; Jason Dufour; Bruce A Bunnell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more
  2 in total

1.  Injectable cartilaginous template transformed BMSCs into vascularized bone.

Authors:  Xiaoke Feng; Zhiye Li; Jianhua Wei; Zhihong Feng; Wei Wu; Yimin Zhao
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

2.  Bone Marrow Mesenchymal Stromal Cells (BMMSCs) Augment Osteointegration of Dental Implants in Type 1 Diabetic Rabbits: An X-Ray Micro-Computed Tomographic Evaluation.

Authors:  Nabeeh Abdullah Alqahtani; Harish C Chandramoorthy; Sharaz Shaik; Jamaluddin Syed; Ramesh Chowdhary; Leoney Antony
Journal:  Medicina (Kaunas)       Date:  2020-03-25       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.